Skip to main content

It mainly occurs in the arteries leading to the legs and feet, and is often the result of atherosclerosis, where fatty deposits build up in the walls of arteries.

Symptoms of PAD will depend of which body part is affect, but may include:

  • intermittent or irregular pain during activity and rest, usually in the legs
  • numbness or pins and needles
  • blackened or loss of areas of skin

The impact

Around 202 million people around the world are living with PAD.1 Approximately 50 per cent of people with PAD show no symptoms, leading to under-diagnosis and under-treatment.2

While PAD is not immediately life threatening, someone with PAD is up to six times more likely to have a heart attack or stroke.3

In addition, the reduced blow flow to the limbs can lead to the limb developing gangrene, where it starts to decay and die. There is no cure for gangrene. The only treatment option is to amputate the affected limb to prevent the gangrene from spreading further in the body.

The risk

Diabetes is the most significant risk factor for PAD. People with type 2 diabetes are three to four times more likely to develop cardiovascular conditions such as PAD, so early detection and management of diabetes is vital.

Other risk factors for PAD include:

  • smoking
  • obesity or being overweight
  • inactivity
  • high blood pressure
  • high cholesterol.

Risk factors that cannot be controlled include age, and medical or family history of cardiovascular disease.

Simple lifestyle changes can help to manage these risk factors, as well as PAD itself after diagnosis.

What is HRI doing?

HRI is tackling the urgent problem of cardiovascular diseases such as PAD from a broad range of research angles.

Our Vascular Complications Group is investigating alternative approaches to stimulate new blood vessel networks to bypass blockages and restore the blood flow necessary for tissue survival. These findings will reduce the devastating impact of vascular diseases in people.​

References

  1. Fowkes FG et al; Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013 Oct 19;382(9901):1329-40.
  2. Au TB et al; Peripheral arterial disease: Diagnosis and management in general practice; Arteries & Veins; Volume 42, No.6, June 2013 Pages 397-400
  3. Better Health Channel; Peripheral vascular disease.

Give

Every donation to the Heart Research Institute is an investment into the lives of millions.

Help us to make a long-lasting difference by donating now.

Other ways you can help